Pamela A Strisofsky

Bio

Pam joined TL in 1997.  During her tenure with TL, she assisted TL in raising more than $1.1 billion of capital and oversaw the investment of more than $1 billion in early-stage companies, distributing greater than $1.4 billion to TL’s partners.  She is a confidant and trusted resource for all accounting, finance and administration issues with TL’s portfolio companies and periodically represents TL on portfolio company boards, including Sopherion Therapeutics, Celator Pharmaceuticals and Starcite.  While at TL she also served as the Chief Financial Officer for eight years of EnerTech Capital Partners, a venture fund focused on energy related businesses and in the late 90s, she also provided accounting, financial and strategic support to several fledging funds and companies includingSafeguard International Fund, Eastern Technology Council and Internet Capital Group, Inc.   Prior to joining TL, Pam was the Controller/Acting Chief Financial Officer for the clearing and depository subsidiaries of the Philadelphia Stock Exchange.  Previously, she worked at MBNA America as a Finance Officer in its newly formed external-reporting department after the Maryland National Bank’s credit card division began publicly trading.  Pam began her career at BancOne Corporation where she assisted in the evaluation and eventual consolidation of several acquired banks into the BancOne family.   She is a member of the American Institute of Certified Public Accountants (AICPA), the Accountancy Board of Ohio, the National Venture Capital Association (NVCA) Board’s CFO Task Force, the AICPA’s Investment Companies Virtual Expert Panel and the NVCA Audit Committee.  Pam is on the board of the Philadelphia Chapter of the Private Equity CFO Association.  Additionally, Pam is a member of the Fox Chase Cancer Center’s Board of Directors. Pam holds a BS in Finance and International Business from Ohio State University and is a certified public accountant